Top Companies Participating in Fallopian Tube Cancer
Therapeutics Clinical Trials
TRINOVA-2 is evaluating whether trebananib plus pegylated liposomal doxorubicin (PLD) is superior to placebo plus PLD as measured by PFS in recurrent epithelial ovarian, primary peritoneal or fallopian tube cancer
In this Phase II, placebo-controlled, double-blinded, multi-center study, 130 women with advanced ovarian, primary peritoneal, or fallopian tube cancer
were enrolled and received treatment with pertuzumab plus gemcitabine, or gemcitabine alone.
Because fallopian tube cancer
and primary peritoneal cancer are generally considered to be identical to ovarian cancer with respect to the cell of origin, prognosis, and response to chemotherapy, patients with these two malignancies were considered suitable for enrollment in the trial.
Each year ovarian or fallopian tube cancer
causes 140,000 deaths globally - including 14,270 women in the United States, and 220 Oregonians.
She was later diagnosed with Fallopian tube cancer
after being booked into Heartlands Hospital for a hysterotomy.
755) would authorize $100 million over 4 years for research into biomarkers that detect or indicate a woman's risk of ovarian cancer, fallopian tube cancer
, and primary peritoneal cancer.
Fallopian tube cancer
appears to be a part of the hereditary breast-ovarian cancer syndrome associated with BRCA1 and BRCA2 mutations, Dr.
Global Markets Direct's, 'Fallopian Tube Cancer
- Pipeline Review, H1 2012', provides an overview of the Fallopian Tube Cancer
About Fallopian Tube Cancer
The incidence rate of fallopian tube cancers
is estimated to be 0.
SAN DIEGO -- Laparoscopic surgical staging is safe and adequate for patients with apparent stage I ovarian and fallopian tube cancer
, results from a preliminary analysis suggest.
GlobalData's clinical trial report, Fallopian Tube Cancer
Global Clinical Trials Review, H2, 2011" provides data on the Fallopian Tube Cancer
clinical trial scenario.